Cite
[Development of TP53-Targeted Treatment in Esophageal Squamous Cell Carcinoma Using Cancer Genomic Profiling Test].
MLA
Kamata, Toshiki, et al. “[Development of TP53-Targeted Treatment in Esophageal Squamous Cell Carcinoma Using Cancer Genomic Profiling Test].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 46, no. 10, Oct. 2019, pp. 1608–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=31631150&authtype=sso&custid=ns315887.
APA
Kamata, T., Kano, M., Takahashi, M., Murakami, K., Sakata, H., Toyozumi, T., Sekino, N., Yokoyama, M., Okada, K., Shiraishi, T., Ryuzaki, T., & Matsubara, H. (2019). [Development of TP53-Targeted Treatment in Esophageal Squamous Cell Carcinoma Using Cancer Genomic Profiling Test]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 46(10), 1608–1610.
Chicago
Kamata, Toshiki, Masayuki Kano, Masahiko Takahashi, Kentaro Murakami, Haruhito Sakata, Takeshi Toyozumi, Nobufumi Sekino, et al. 2019. “[Development of TP53-Targeted Treatment in Esophageal Squamous Cell Carcinoma Using Cancer Genomic Profiling Test].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 46 (10): 1608–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=31631150&authtype=sso&custid=ns315887.